Pediatric liver transplantation is often required as a consequence of biliary disorders because of the lack of alternative treatments for repairing or replacing damaged bile ducts. To address the lack of availability of pediatric livers suitable for transplantation, we developed a protocol for generating bioengineered biliary tissue suitable for biliary reconstruction. Our platform allows the derivation of cholangiocyte organoids (COs) expressing key biliary markers and retaining functions of primary extra-or intrahepatic duct cholangiocytes within 2 weeks of isolation. COs are subsequently seeded on polyglycolic acid (PGA) scaffolds or densified collagen constructs for 4 weeks to generate bioengineered tissue retaining biliary characteristics. Expertise in organoid culture and tissue engineering is desirable for optimal results. COs correspond to mature functional cholangiocytes, differentiating our method from alternative organoid systems currently available that propagate adult stem cells. Consequently, COs provide a unique platform for studies in biliary physiology and pathophysiology, and the resulting bioengineered tissue has broad applications for regenerative medicine and cholangiopathies.
Introduction
Cholangiopathies comprise a diverse group of disorders characterized by damage to the biliary tree and loss of bile ducts resulting in cholestasis, hepatic injury and ultimately liver failure 1,2 . However, treatment options are limited to liver transplantation. Indeed, biliary disease remains the leading indication for this intervention in children, with >70% of pediatric liver grafts being used to treat biliary atresia 3 . The generation of healthy biliary tissue suitable for replacing or reconstructing damaged bile ducts could address the clinical need for alternative therapeutic approaches and reduce pressure on the transplant waiting list. However, progress in this area has been hampered by challenges in the long-term culture and large-scale expansion of primary cholangiocytes. Here, we describe a protocol for the fabrication of functional bioengineered biliary tissue, using biocompatible and biodegradable scaffolds and a method for the isolation and propagation of primary cholangiocytes in organoid format.
Development of the protocol
To generate bioengineered biliary tissue suitable for surgical manipulation and biliary reconstruction, we decided to combine primary biliary epithelium with appropriate matrices.
Development of the protocol for CO culture First, we developed a culture protocol for the propagation and large-scale expansion of primary adult, functional cholangiocytes 4 . Because biliary reconstruction is predominantly performed on the common bile duct (CBD), we initially focused on the isolation of CBD cholangiocytes, using excised bile ducts from deceased organ donors. To achieve expansion of the isolated cholangiocytes, the cells are embedded in Matrigel and treated with a combination of epidermal growth factor (EGF), R-spondin-1 and DKK-1. We have previously demonstrated that the combination of EGF and 3D culture can promote limited growth of partially mature, fetal cholangiocyte-like cell (CLC) organoids derived from induced pluripotent stem (iPS) cells 5, 6 . In addition, primary adult stem cell organoids have been isolated from murine biliary tissue 7 . To support the long-term expansion of adult cholangiocytes, we use R-spondin-1, a WNT agonist reported to stimulate organoid derivation from multiple adult epithelia [8] [9] [10] [11] [12] [13] . However, R-spondin promotes the propagation of adult stem cells rather than mature epithelial populations by enhancing canonical Wnt signaling 14 . To avoid the amplification of adult stem cells, we introduce DKK-1 15 , a canonical WNT/β-catenin pathway antagonist 16, 17 . When used in combination with R-spondin, DKK-1 inhibits canonical and enhances non-canonical WNT signaling through the planar cell polarity pathway 4 , which has been reported to play a role in cholangiocyte maturation 18, 19 . The combination of EGF, R-spondin-1 and DKK-1 allows for long-term, large-scale expansion of functional, genetically stable, primary adult COs.
Our system was developed and optimized for the culture of CBD COs isolated from fresh excised bile ducts. However, this isolation method requires a complex operation, thereby posing substantial limitations related to access to biliary tissue. To overcome this issue, we subsequently validated the capacity of our culture system for the derivation of COs from multiple sources, such as excised gallbladders, endoscopic retrograde cholangiopancreatography (ERCP) brushings and liver biopsy samples. With this platform, COs can be isolated and expanded using samples from any area of the biliary tree and acquired by any of these isolation methods.
Choice of scaffolds Our next goal was to identify appropriate scaffolds that could be combined with the cells to generate tissue-like constructs. Important considerations for the choice of scaffolds were their potential to support growth of the cells, their capacity to be integrated into the host tissue following transplantation with minimal inflammatory response and the use of biodegradable materials allowing for tissue remodeling, which is critical to neo-vascularization. Furthermore, to support future clinical translation, the materials used should be compatible with human transplantation.
Importantly, both synthetic and biological polymer scaffolds with these specifications are available. As there are advantages and disadvantages associated with each approach, we decided to explore both. Synthetic polymer scaffolds are widely used, as they can be easily processed using a wide range of techniques and adapted for multiple tissue engineering applications 20 . They have tunable and reproducible physicochemical properties, mechanical strength and degradation rates, making them highly customizable as a scaffold material 20, 21 . Biological polymer scaffolds are more challenging to tailor to a particular application, owing to purity, immunogenicity, and scaffold homogeneity and reproducibility issues 22 . However biological polymer scaffolds have superior bioactive properties (e.g., cell attachment, migration, cell scaffold remodeling) and thus better cell and tissue interactions 22, 23 .
Generation of bioengineered tissue using synthetic scaffolds First, we focused on synthetic scaffolds commercially available 'off the shelf' to optimize cell seeding, attachment and culture of the resulting tissue. We decided to use a PGA matrix because of its biodegradability, flexibility and lack of inflammatory response in vivo 24 . In addition, synthetic PGA scaffolds can be easily processed into tailored architectures 22, 23 . For these reasons, PGA is one of the most commonly used synthetic polymers in tissue engineering 21 and has been approved by the FDA for use in human studies 25 . We subsequently identified the optimal method for seeding COs on the scaffolds. Our results demonstrated that the use of cell clumps concentrated in small volumes is the optimal seeding method. Small volumes of cell suspension are absorbed by the scaffold, maximizing cell-to-scaffold contact. An alternative method, the dissociation of organoids into single cells, requires aggressive enzymatic digestion, which reduces cell viability and attachment because of the cleavage of multiple cell-to-matrix adhesion molecules 26 . Seeding cell clumps resulted in the generation of confluent PGA scaffolds seeded with COs, which were used to successfully repair biliary tree wall defects in immunocompromised mice following transplantation.
Generation of bioengineered tissue using biological scaffolds
We subsequently used the same seeding methodology to populate biological scaffolds. Here, we chose densified collagen hydrogel because of its biocompatibility, low immunogenicity, ability to favor cell attachment and growth, biodegradability and ability to be naturally remodeled by cells 27 . Importantly, as compared with standard collagen gel, densified collagen gel demonstrates superior mechanical properties for surgical applications 27, 28 . Densification expels the majority of the water content of the collagen gel, vastly reducing its volume, resulting in a polymer scaffold of higher concentration and fibrillar alignment 28 . Through the use of appropriate molds, the densification process can be customized to generate constructs of more complex geometries, which can be successfully seeded with COs.
Generation of bioengineered mouse bile ducts
One of the most relevant clinical applications of bioengineered biliary tissue is the generation of tubular constructs suitable for biliary reconstruction. However, bile duct transplantation can be associated with a substantial inflammatory response, epithelial damage and the formation of anastomotic strictures in humans 29, 30 . Consequently, in vivo validation of the function, biocompatibility and patency of bioengineered ducts following reconstruction is required. To achieve this goal, we decided to generate bioengineered constructs populated with human COs, transplant them into immunocompromised mice and characterize them.
The fabrication of tubular structures with dimensions comparable to those of the mouse CBD (250-µm inner diameter and 30-µm wall thickness) was a key challenge. Indeed, commercially available fibrous PGA scaffolds 31 were incompatible with these requirements because their minimum thickness (300 µm) is substantially larger than the required wall thickness. Appropriate-thickness predensified collagen gel sheets could be fashioned into a tube using sutures; however, interruption of the collagen fibrils along the seam led to partial collapse of the lumen under the weight of the wall. To overcome these challenges, we developed a method in which collagen was cast around a central rod and densified afterward, to yield a seamless tube with a thin and robust wall. Furthermore, a conical funnel mold was used, which allowed a proportionately large volume of collagen to densify into a short length of tube and enabled efficient water removal via multiple routes (through on-axis absorption and radial evaporation). These techniques yielded bioengineered tubes with a patent lumen and dimensions similar to those of the mouse CBD 32 . We subsequently used the approach that we developed for seeding COs on flat collagen scaffolds to seed the luminal surface of the construct with cells and generate mouse-sized bioengineered bile ducts populated with human cells. Importantly, the potential of these constructs for biliary reconstruction in vivo was illustrated through their successful transplantation into immunocompromised mice 4 .
Applications and target audience
The propagation of COs and the generation of bioengineered biliary tissue are likely to be of interest to a broad scientific audience, including clinician scientists focusing on translation of new therapies to the clinic, bioengineers working on whole-organ reconstruction, groups focusing on biliary physiology and disease and the pharmaceutical industry. Currently the only therapeutic option for biliary disorders is liver transplantation. The generation of bioengineered biliary tissue could provide one of the first alternative treatments and pioneer the use of regenerative medicine for cholangiopathies 33, 34 . Furthermore, a limitation of complex liver co-culture systems is the lack of a biliary system. The capacity of COs to grow in a variety of matrices and scaffolds makes them an ideal addition to complex tissue engineering applications that focus on recapitulating the microanatomy of the liver and the development of artificial whole-organ systems 35 . Cholangiocytes constitute a rare liver cell type, and access to primary tissue has limited large-scale analyses in the past. COs closely resemble primary biliary epithelium in terms of transcriptional profile and function 4 characteristics and functionality with no need for additional differentiation. Therefore, our system is distinct from alternative primary organoid platforms based on canonical WNT signaling, which propagate adult stem cells 8, 11, 13, 36 rather than bona fide biliary epithelium. Consequently, COs may be better suited to studies on biliary physiology and disease requiring high-fidelity cholangiocytes, whereas adult stem cells are optimal for studies on liver repair and regeneration.
Although methods for short-term culture of murine 37 and human primary cholangiocytes have been reported 38, 39 , these systems are technically challenging and allow for only limited expansion, restricting large-scale analyses, and the function of the resulting cells has not been extensively characterized. COs combine high proliferative capacity, increased functionality and the potential for large-scale expansion, which is critical to regenerative medicine or for high-throughput applications.
Importantly, cholangiocytes can be derived from iPS cells 5, 6, 40, 41 . However, these cells have the characteristics of fetal intrahepatic cholangiocytes, whereas our method can generate cells similar to both intrahepatic and extrahepatic adult cholangiocytes. In addition, COs can be rapidly isolated and expanded, unlike iPS cell systems, which require a lengthy differentiation process and cannot be further propagated once terminally differentiated. Consequently, stem cell-derived cholangiocytes are optimal for studies of intrahepatic bile duct development and its disorders, whereas COs are better suited to studies of adult intra-and extrahepatic cholangiocyte physiology or regenerative medicine applications requiring large numbers of highly functional cells in little time.
Our system provides multiple advantages for tissue engineering and regenerative medicine. The generation of bioengineered tissue is versatile, allowing the use of synthetic (PGA) or biological scaffolds (collagen). Furthermore, it is compatible with Good Manufacturing Practice (GMP)-compliant materials, such as collagen, which has an excellent in vivo profile and is used extensively in clinical applications 24 . The method by which the densified collagen tubes are formed allows their generation at customizable length scales compatible with small animal studies. Furthermore, the densification process does not impart substantial stress upon the cells, which can be mixed in the gel if required. The resulting constructs can be maintained for >2 months in culture, enabling the generation of large batches of bioengineered tissue with prolonged 'shelf life'. Importantly, our bioengineered biliary tissue provides the first proof of principle for organ reconstruction using primary epithelial organoids, in which the resulting bioengineered construct was used to fully replace the native organ 4 .
Limitations
A limitation of our system is that COs, as adult primary cholangiocytes, are not suitable for studying biliary development, an application for which stem cell-derived systems are more appropriate. In addition, as COs represent a pure epithelial population, this system does not currently allow for the study of epithelial and mesenchymal interactions, although the potential exists within our system to generate bioengineered tissue with additional cell types. A further, technical, limitation is that COs currently rely on the use of Matrigel, a non-GMP-compliant extracellular matrix. However, multiple chemically defined hydrogel matrices, which could replace Matrigel, are currently in development 42 . For research groups without access to a hospital with hepatobiliary services, access to primary tissue may present a challenge, as primary samples must be processed promptly following isolation. We note that samples can be obtained in any hospital that offers a cholecystectomy, ERCP or liver biopsy service, and that organoid derivation is still feasible after small delays associated with tissue transfer over short distances. Nevertheless, to compensate for transport-associated delays when multiple samples from distal centers are processed, a team of trained technicians working in parallel may be required.
Finally, although mouse-sized (submillimeter) constructs serve as proof of principle for the generation of bioengineered ducts populated with human cells, their mechanical properties do not translate to those of the human bile duct (7-mm diameter, 1-mm wall thickness). Therefore, optimization of our technique for the generation of human-sized constructs with appropriate physical attributes will be required before clinical translation.
Experimental design
Our method describes a system for isolating primary extrahepatic and intrahepatic cholangiocytes from primary tissue, culturing these primary cholangiocytes in a 3D organoid system and generating bioengineered biliary tissue using artificial scaffolds (Fig. 1) . In this section, we describe infrastructure and experimental setup considerations that one must take into account before using this protocol.
Isolation of cholangiocytes from primary tissue
Our protocol requires the isolation of cholangiocytes from primary human tissue, either from living patients or from deceased organ donors. As such, appropriate ethical approval from the relevant regulatory bodies is required, and informed consent is essential before any human tissue samples are acquired. Step 40C
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Collagen tube Obtaining fresh human tissue samples will require access to a hospital with one of the following services: hepatology, advanced endoscopy, hepatobiliary surgery, transplant organ procurement or liver transplantation. Importantly, donor tissue viability decreases in proportion to ex vivo storage and bile exposure. Therefore, bile must be flushed from the tissue, which should then be stored immediately in cold preservation solution (such as University of Wisconsin (UW) solution) or supplemented William's E+ medium at 4°C until it can be processed 43 . When multiple tissue samples are obtained simultaneously (such as from a deceased organ donor), the tissue should be processed in order of sensitivity to cold storage ( Supplementary Fig. 1 ). Liver biopsies require immediate processing, whereas extrahepatic tissue can be stored at 4°C for several hours, provided that it is appropriately flushed of bile. Furthermore, all tissue handling should be performed under aseptic conditions to avoid contamination. Consequently, good communication with the clinicians obtaining the sample is critical. Long-distance transport of samples is likely to impact the viability of explanted tissue, so samples must ideally be processed in a facility close to the site of collection. Tissue must be processed in a class II biological safety cabinet under aseptic conditions, and sterile surgical equipment must be used.
CO lines can be generated using multiple approaches, depending on the source of available tissue and the method of sample collection (Fig. 1) . Surgically excised tissue samples, such as gallbladders and bile ducts, can be used for the generation of COs following isolation of the luminal layer of cholangiocytes through mechanical scraping (Fig. 2) . ERCP brushings provide an alternative source of tissue for patients having endoscopy (Fig. 3) . One can isolate COs from liver biopsy tissue by dividing a liver biopsy core into small pieces (~1 mm 3 ) and plating them directly in CO organoid culture conditions (Fig. 4) . Alternatively, CO lines can be derived from a population of EpCAM + sorted single cells ( Supplementary Fig. 2 ). Tissue can be enzymatically digested to a single-cell suspension and then EpCAM-sorted through either FACS or magnetic-activated cell sorting (MACS).
Provided the tissue has been appropriately and promptly processed, the methods described should produce CO lines with almost 100% efficiency, apart from EpCAM sorting, which yields viable lines with an efficacy of 66% (Supplementary Table 1 ) owing to the impact of single-cell dissociation on cell viability. This method of derivation will produce a highly purified CO population, in contrast to derivation from whole-liver tissue, which can take up to three passages to establish a pure CO population. Flushing the tissue of bile is critical to achieving these results. Indeed, derivation efficiency is reduced from 95% to 40% if flushing is not performed (Supplementary Table 1 ). The optimal technique for CO line derivation should be decided on the basis of sample availability and access to tissue.
Establishment and maintenance of COs
Once plated, primary cholangiocytes should form organoids in 3-10 d. Clump size and seeding density can affect the speed and efficiency of derivation. Single cells tend to require longer culture and yield lower numbers of organoids from the same number of starting cells. Large clumps of >50-100 cells and high seeding density may result in cell attachment and limit organoid growth.
CO lines should be passaged approximately every 5 d (Fig. 5 ), although the cells should be monitored daily to check whether confluency has been reached (Fig. 5b, Supplementary Fig. 3 ). Delays in passaging of confluent wells can result in organoid collapse and affect the long-term health of the organoid line ( Supplementary Fig. 4b ). The same considerations as for organoid derivation apply with regard to clump size and seeding density during passaging ( Supplementary Fig. 4b ). Importantly, our protocol relies on Matrigel as an extracellular matrix, which has a profound impact on the quality of the resulting organoid lines. Therefore, Matrigel must be batch-tested before use. It is also important to ensure that no reagent or medium used in the maintenance of CO lines is used for longer than 3 months, as this can impact organoid quality.
Organoids can be analyzed through a variety of methods, such as qPCR, immunofluorescence (IF) and flow cytometry, as we have previously described 5, 6 . COs should show robust expression of key biliary markers such as cytokeratin 19, cytokeratin 7, Sox9 and gamma-glutamyl transferase (GGT), as well as key cholangiocyte functions such as alkaline phosphatase (ALP) and GGT activity (Fig. 6 ), which can be used to assess the quality of CO derivation and culture.
Scaffold preparation
Bioengineered tissue can be generated using both synthetic (PGA) and biological (densified collagen gel) polymeric scaffolds, each of which may be suited to different applications. PGA scaffolds can be commercially sourced, are cheap and require minimal processing to yield positive results.
The mechanical properties of the scaffold (e.g., Young's modulus, strength) are tunable and can be customized through adjustment of the density and pore size. Furthermore, PGA constructs can be easily fabricated into custom architectures 22, 23 . Supplementary Fig. 6 ). APC, allophycocyanin; FITC, fluorescein isothiocyanate.
Collagen constitutes a physiological component of the extracellular matrix 44 with high bioactivity 45 , which can interact with cells and present multiple cues that enhance attachment, survival, proliferation and tissue remodeling 44, 46 . Furthermore, unlike PGA, cells can be mixed directly into the collagen gel precursor solution before gelation and densification, generating a uniform network of cells throughout the scaffold, which is useful for applications such as complex co-culture systems. However, it is more expensive than synthetic alternatives, and scaffolds with adequate mechanical strength for surgical manipulation 47, 48 are not commercially available and need to be custom-made. Indeed, densified collagen sheets must be fabricated from collagen gels through water absorption (Fig. 7) , whereas densified collagen tubes must be formed through molding of collagen gel around a cylindrical template and water removal by evaporation from the gel surface (Fig. 8) . Consequently, Supplementary Fig. 6 ). APC, allophycocyanin; FITC, fluorescein isothiocyanate.
densified collagen scaffolds are more physiological but require a higher level of expertise and pose a greater number of potential pitfalls, whereas PGA scaffolds may be appropriate for settings in which the expertise and equipment for the generation of custom-made scaffolds are not available.
Scaffold seeding
PGA and densified collagen scaffolds (both flat and tubular) can be seeded with COs to generate bioengineered biliary tissue within 2-4 weeks. The cells are seeded as clumps in small volumes to maximize their contact with the scaffold and are incubated for 1 h to allow attachment before the addition of medium. For tubular scaffolds, cannulation with a small-gauge (<30-gauge) needle is necessary for seeding. This procedure is technically challenging and may require the assistance of a surgeon to avoid damaging the scaffold. Supplementary  Fig. 6 ). APC, allophycocyanin; FITC, fluorescein isothiocyanate.
PROTOCOL
NATURE PROTOCOLS
The efficiency and quality of cell attachment following seeding (Figs. 9 and 10) depend on clump size, cell number, seeding cell suspension volume and drying time for the scaffold. Single cells and low cell numbers are associated with reduced seeding efficiency, whereas large clumps may attach only partially. Importantly, parts of a clump that have not attached may remodel to form organoid-like structures connected to the scaffold or overlap with neighboring clumps that have attached, generating a pseudostratified epithelium. Consequently, the use of 30-50 cell clumps is critical to achieving optimal seeding results.
Low cell-suspension volumes result in poor scaffold coverage and therefore suboptimal seeding, whereas cell viability may be reduced because of medium evaporation during the incubation period. High volumes may lead to overflow and 'spillage' of the cell suspension from the scaffold to the plate, resulting in a reduced cell-to-surface ratio and poor seeding efficiency. Consequently, the seeding volume must be optimized on the basis of the scaffold surface, as described in the Procedure. This is particularly important when seeding on the luminal surface of a tubular scaffold, where the cell suspension must be optimized for minimal volume and maximal density, to be contained within the tube lumen.
Reduced incubation time does not allow an adequate period for the cells to attach. Consequently, the addition of medium at the end of the incubation phase results in washing of poorly attached cells off the scaffold. Prolonged incubation can result in scaffold drying and reduced cell viability.
Importantly, the scaffold is rarely confluent following seeding. Indeed, in most cases only a proportion of the scaffold is covered with cells. However, these expand to generate a confluent layer within weeks. The time to confluency can be reduced by seeding of higher numbers of cells or by repeated rounds of seeding. Importantly, if an additional round of seeding is performed, the scaffold should not be allowed to dry before the new cells are added, in order to preserve the viability of the cells already attached.
Bioengineered biliary tissue can be analyzed through IF or functional assays as previously described 4 and should show robust expression of key biliary markers such as cytokeratin 19 and cytokeratin 7 (Fig. 11a,c,e) , as well as key cholangiocyte functions such as GGT activity (Fig. 11b,d,f) . Once confluent, the scaffolds can be transplanted in vivo or maintained in culture for several months.
Scaffold-specific considerations
Pore size is an important consideration for PGA scaffolds. The scaffold pore size will determine the optimal cell clump size for seeding. Scaffolds with large pores would, in principle, allow deeper cell 49 . c, COs (10 passages) demonstrate ALP activity. Scale bars, 100 μm. ALP assays were conducted as previously described 5 . d, GGT activity of COs (20 passages) measured in absorbance units (a.u.); n = 3; MEFs (mouse embryonic feeders) were used as a negative control. Error bars, s.d.; individual data points are demonstrated; ** P < 0.0001, two-tailed Student's t-test. GGT activity was assessed using a commercially available kit (MaxDiscovery gamma-Glutamyl Transferase (GGT) Enzymatic Assay Kit) according to the manufacturer's instructions and as previously described 5 . e, Flow cytometric analyses performed on COs after long-term culture (20 passages), demonstrating >99% CK7
+ expression (gating strategy demonstrated in Supplementary Fig. 6 ). APC, allophycocyanin; FITC, fluorescein isothiocyanate.
penetration, provided there is good interconnectivity between pores. However, constructs with larger pores are weaker, and seeding with large clumps is required to ensure that the cells do not 'fall through' the spaces between fibers. Furthermore, preparation of the scaffolds for seeding includes treatment with ethanol (EtOH) and concentrated sodium hydroxide (NaOH). It is critical that, at the point of seeding, the scaffold be completely free of EtOH or NaOH remnants, which could result in cell death and poor attachment.
For collagen scaffolds, the quality of collagen plays a key role in the attachment and growth of cells. As collagen solutions are not 100% pure, we recommend testing of each new collagen batch for cell attachment, proliferation, expression of biliary markers and function.
For the generation of tubular densified collagen scaffolds, assistance of an experienced engineer and access to engineering facilities, including a 3D printer, are essential. Furthermore, transplantation of bioengineered ducts into small animal models requires substantial skill because of the construct size, and the procedure must be performed by an experienced surgeon.
Appropriate controls
Freshly isolated primary biliary tissue should be used as a positive control for the expression of biliary markers. For histology or IF analyses, whole tissue can be frozen in optimal cutting temperature compound (OCT) or fixed in 10% (vol/vol) formalin and embedded in paraffin for sectioning. Cells can be isolated as described in Steps 2A and 2D and dissociated to a single-cell suspension for flow cytometry or resuspended in RNA lysis buffer for RNA extraction and qPCR, as described in
Step 41C. Alternatively, RNA can be extracted from snap-frozen tissue. Although primary tissue represents the ideal control for CO function and marker expression, it is also possible to compare COs with established cholangiocyte cell lines if access to primary tissue is not possible.
Starting population considerations
We have demonstrated that our protocol for CO derivation is reproducible with >70 CO lines (Supplementary Table 1 ). In addition, CO lines can be generated from very low numbers (<20,000) of viable primary cells ( Supplementary Fig. 5 ). CO lines can be maintained in culture for >20 passages or 6 months. COs represent primary cells rather than immortalized cell lines; therefore it is possible that a reduction in the growth potential or function of the line will be observed after this time. The 'incubator life' of each line varies, and therefore the expansion potential, expression of biliary markers and function should be regularly tested after passage 20 to periodically validate the quality of the line.
For the generation of bioengineered tissue, some variability in cell attachment and expansion potential following seeding and after transplantation is expected. Therefore, minor optimization may be required for certain CO lines, as described in the following sections.
Materials Biological materials
• Human bile duct (minimum 1-cm length), gall bladder (minimum 1-cm 2 area) or liver tissue samples (minimum 5-mm 3 whole-liver piece or two core needle biopsies, if following Step 2C, or minimum 2 × 1-cm 2 whole-liver pieces, if following Step 2D) or cholangiocytes from ERCP brushings. ! CAUTION All human tissue samples must be collected with the appropriate ethical approval in place and with full informed consent. Donors should be tested to exclude use of HIV-, hepatitis B-or hepatitis C-infected material. Informed consent was obtained for the use of all human tissues used in our experiments. Approval for our experiments was obtained from the NRES Committee East of England, Cambridge South (REC reference 15/EE/0152). • L-Phospho-ascorbic acid (Sigma Life Sciences, cat. no. • Deionized ( of key biliary markers in CO-seeded PGA scaffolds (6 weeks after seeding). Scale bar, 100 μm. b, CO-seeded PGA scaffolds demonstrate GGT activity (4 weeks after seeding). n = 3; MEFs used as a negative control. Error bars, s.d.; individual data points are shown; **** P < 0.0001, two-tailed Student's t-test. c, Immunofluorescence images showing expression of key biliary markers in CO-seeded densified collagen sheets (4 weeks after seeding). Scale bar, 100 μm. d, CO-seeded collagen scaffolds demonstrate GGT activity (4 weeks after seeding). n = 3; MEFs used as a negative control. Error bars, s.d.; individual data points are shown; ** P = 0.0055, two-tailed Student's t-test. e, Immunofluorescence images showing expression of key biliary markers in CO-seeded densified collagen tubes (6 weeks after seeding). Scale bar, 100 μm. f, CO-seeded collagen tubes demonstrate GGT activity (4 weeks after seeding). n = 3; MEFs used as a negative control. Error bars, s.d.; individual data points are shown; **** P = 0.0001, two-tailed Student's t-test. GGT activity was assessed using a commercially available kit (MaxDiscovery gammaGlutamyl Transferase (GGT) Enzymatic Assay Kit) according to the manufacturer's instructions. a.u., absorbance units; MEFs, mouse embryonic feeders.
Reagents
• Hoechst 33258 (Sigma-Aldrich, cat. c CRITICAL Sterilize the nicotinamide stock solution using a vacuum filter/storage bottle system. Mix it well before filtration. Store the solution at 4°C for up to 3 months.
Sodium bicarbonate 1 M stock solution Dissolve 42 g of sodium bicarbonate powder in 500 ml of embryo transfer water.
c CRITICAL Sterilize the sodium bicarbonate stock solution using a vacuum filter/storage bottle system. Mix it well before filtration. Store the solution at 4°C for up to 3 months.
Ascorbic acid trisodium salt 100 mM stock solution Dissolve 16.1 g of ascorbic acid trisodium salt powder in 500 ml of embryo transfer water. c CRITICAL Sterilize the ascorbic acid trisodium salt stock solution using a vacuum filter/storage bottle system. Mix the solution well before filtration. Store it at 4°C for up to 3 months. Protect it from light. D-Glucose 1 M stock solution Dissolve 90.1 g of D-glucose powder in 500 ml of embryo transfer water. Warm the mixture to 50°C to facilitate dissolution.
c CRITICAL Sterilize the D-glucose stock solution using a vacuum filter/storage bottle system. Mix the solution well before filtration. Store it at 4°C for up to 3 months.
Dexamethasone 10 mM stock solution Dissolve 100 mg of dexamethasone in 25.4797 ml of DMSO. Prepare 50-to 100-μl aliquots. Store them at −80°C for up to 12 months.
Supplemented William's E medium (William's E+ medium)
Mix 443 ml of William's E medium with 12.5 ml of nicotinamide stock solution, 8.5 ml of sodium bicarbonate stock solution, 1 ml of ascorbic acid trisodium salt stock solution, 7 ml of glucose stock solution, 3.15 ml of sodium pyruvate, 10 ml of HEPES solution, 5 ml of ITS+ premix, 5 μl of dexamethasone, 5.3 ml of glutamine and 5 ml of pen-strep. c CRITICAL Sterilize William's E+ medium using a vacuum filter/storage bottle system. Mix the medium well before filtration. Store it at 4°C for up to 1 month. Warm it to 37°C before use.
Sodium bicarbonate 7.5% (wt/vol) stock solution Dissolve 3.75 g of sodium bicarbonate powder in 46.25 ml of DI water. c CRITICAL Sterilize the sodium bicarbonate stock solution using a 50-ml syringe and a 0.2-μm syringe filter. Mix it well before filtration. Store the solution at 4°C for up to 3 months.
70% (vol/vol) EtOH
Mix 700 ml of absolute EtOH and 300 ml of DI water. This solution can be stored indefinitely.
Matrigel 10-ml Matrigel vials should be thawed slowly in a refrigerator at 4°C overnight. Thawed Matrigel should be mixed well and then divided into 1-ml aliquots. Aliquots of Matrigel should always be made in a class II biological safety cabinet to avoid bacterial contamination. Matrigel should be kept constantly on ice to avoid solidification. All equipment coming into contact with Matrigel should be precooled to 4°C. This includes pipette tips and media for diluting Matrigel. Tubes used for making aliquots should be kept on ice. Store Matrigel aliquots at −20°C or −80°C for up to 3 months. c CRITICAL Each aliquot should undergo a maximum of two freeze-thaw cycles. This can be achieved by adjusting aliquot volumes accordingly.
3× supplemented William's E+ solution Supplement William's E+ medium with 1.5 μg/ml R-spondin-1, 300 ng/ml DKK, 150 ng/ml EGF and 3 μM Y27632 (3× is the typical concentration for all supplementary cytokines). The supplemented medium should be prepared immediately before use and should not be stored.
Matrigel-supplemented William's E+ solution droplets
COs are cultured in 3D conditions, suspended in 50-μl droplets composed of a 66.7% (vol/vol) Matrigel and 33.3% (vol/vol) 3× supplemented William's E+ solution, which form a dome after plating (Fig. 4b , image 6(i)). Before plating, prepare a master mix with a volume corresponding to the number of droplets that will be plated (as described in Steps 3-10). Importantly, for generating this master mix, COs or primary cholangiocytes are first resuspended in the 3× supplemented William's E+ solution ( Step 3) and Matrigel is subsequently added (Step 5). To calculate the volume of supplemented William's E+ solution needed for resuspension of the CO pellet, the following formula can be used:
Volume of supplemented William's Eþ medium¼ Number of CO wells ð Þ 50 μl ½ =3
The master mix must be kept at 4°C and used immediately after preparation. c CRITICAL As the volume of medium needed to resuspend the CO pellet will typically be very small, it is advisable to instead prepare a larger volume of 3× concentrated William's E+ solution. This can then be diluted to 1× and added to the wells after plating as their plating medium. This volume corresponds to 1/3 of the total number of wells to be plated (e.g., if plating 12 wells, prepare 4 ml of 3× William's E+ solution), assuming 1 ml of medium/well is used. A small aliquot of the resulting 3× solution can then be used to resuspend the pellet, and the remaining solution can be diluted to 1× with William's E+ medium devoid of additional cytokines and used as plating medium. 
Liberase
Reconstitute the lyophilized Liberase enzyme with 10 ml of sterile embryo transfer water, per the manufacturer's instructions, to obtain a stock solution.
c CRITICAL Divide the reconstituted Liberase stock solution into 1-ml aliquots to avoid repeated freeze-thaw cycles and store at −15°C to −25°C for up to 6 months. Reconstitution and aliquot preparation should take place in a class II biological safety cabinet to avoid contamination.
DNase I
Reconstitute the lyophilized DNase I to a 4 mg/ml stock solution using sterile PBS. c CRITICAL Divide the reconstituted DNase I stock solution into 100-μl aliquots to avoid repeated freeze-thaw cycles and store at −80°C for up to 6 months. Reconstitution and aliquot preparation should take place in a class II biological safety cabinet to avoid contamination.
1% (wt/vol) BSA in PBS
Weigh out 5 g of BSA powder and dissolve in 500 ml of PBS to obtain a 1% solution.
c CRITICAL Sterilize 1% (wt/vol) BSA in PBS solution using a vacuum filter/storage bottle system. Mix the solution well before filtration. Prepare aliquots in 50-ml centrifuge tubes and store at −20°C to avoid contamination.
MACS buffer
Prepare a 1-in-20 dilution of MACS BSA stock solution in AutoMACS rinsing solution. c CRITICAL MACS buffer should be freshly prepared at the point of use and should be kept at 4°C. Buffer preparation should take place in a class II biological safety cabinet to avoid contamination.
0.1% (vol/vol) Triton X-100 solution Add 50 μl of Triton X-100 to 50 ml of PBS in a 50-ml centrifuge tube. Gently shake the tube by inversion until the Triton X-100 is fully dissolved. This solution can be stored at room temperature (23°C) for up to 3 months or at 4°C for up to a year.
Equipment setup
Plate heater setup Clean the plate heater with Trigene and 70% (vol/vol) EtOH and place it in a class II biological safety cabinet. Set the temperature to 37°C and place a 24-well plate on the heating surface. c CRITICAL Allow a minimum of 30 min for the plate to warm up before plating Matrigel with cells. If you are using multiple plates, these can be prewarmed in an incubator for a minimum of 30 min, with each plate placed on the plate heater immediately before plating.
AutoMACS Pro Separator setup
Run column exchange before use. Check that the columns are secured and that there are no leaks anywhere in the system. Check that there is sufficient running buffer, washing solution and 70% (vol/vol) EtOH and that the waste bottle is not too full. Run an additional 'Qrinse' before starting cell sorting. To save time, this can be done while the cells are incubating with the MACS beads. To shut down the machine after EpCAM sorting, select the 'Sleep' program. Turn off the machine once the 'Sleep' program has finished.
Fabrication and assembly of densification chamber for densified collagen tubes
The densification chamber, used to form the densified collagen tubes, requires fabrication and assembly ahead of the collagen gel preparation. This involves 3D printing of the base and funnel pieces, mounting a rigid metal wire in the base and fixing paper towels between the base and funnel as follows. 1 Design the chamber geometry using a CAD package (e.g., Autodesk Inventor). See Supplementary Software 1 and 2 for examples of designs we have used successfully. 2 Export the design as a .stl file and prepare the file for 3D printing using 3D printer software (e.g., Doraware). 3 3D-print the chamber model using polylactic acid filament and assemble the components shown in Fig. 8a , image 1. 4 Mount a straight rigid wire in the hole in the base piece of the chamber by gluing it into place with superglue (Fig. 8a, image 2) . c CRITICAL STEP Let the superglue cure before continuing (1 h). 5 Fold two sheets of absorbent precision wipes four times and, using scissors, cut to the size of the base plate. Autoclave these paper towels in an autoclave pouch. c CRITICAL STEP Let the towels dry fully before continuing. 6 Sterilize the base plate and funnel piece by immersion in 70% (vol/vol) EtOH. 7 Place the 3D-printed components under a sterile class II biological safety cabinet until dry. 8 Autoclave 4× M4 screws and nuts. 9 Using a sterile 23-gauge needle, punch a hole through the center of the sheets and feed the mounted metallic wire through the needle (Fig. 8a, image 3) .
10 Remove the 23-gauge needle and push the paper towels down. 11 Feed the metallic wire through the funnel piece (Fig. 8a, image 4) and fix the funnel piece to the base piece, using 4× M4 screws and nuts (Fig. 8a, image 5 ). 12 Tighten the screws, using a screwdriver. The chamber is now ready for the densification process. c CRITICAL STEP The screws must be tight in order to prevent leakage of water into the towels before a collagen gel forms. c CRITICAL STEP The top of the metallic wire must not extrude above the top of the funnel. This is a necessary condition for successful collagen densification for tube formation. (Fig. 1b) . Once collected, tissue should be stored immediately as described in the 'Reagent setup' section.
Procedure
! CAUTION Dissection of tissue should take place in a class II biological safety cabinet under aseptic conditions. j PAUSE POINT Tissue can be kept in medium/cold storage solution for up to 8 h, although for optimal viability, tissue should be processed as soon as possible after collection. Guidance on the maximum length of storage before processing for each tissue type is shown in Supplementary Fig. 1 . (ii) Using a scalpel and forceps, make a longitudinal incision along the length of the excised bile duct or from the fundus to the neck of the excised gallbladder (Fig. 2b, images 1A (ii) and 2) to expose the lumen. This step should result in a flat sheet of biliary tissue with the biliary epithelium on the luminal surface, usually pigmented yellow by bile, and an 'exterior' surface corresponding to the outer wall of the bile duct or gallbladder. ! CAUTION Ensure the luminal surface is facing upward to avoid the loss of cholangiocytes. (iii) Wash the tissue by transferring it to a 50-ml centrifuge tube containing PBS to remove excess bile (Fig. 2b,c, image 2 ). Repeat twice, using a fresh tube each time. c CRITICAL STEP PBS washes must be performed cautiously to prevent detachment of the biliary epithelial layer. This is particularly important if the bile duct or gallbladder tissue has been kept on ice for <2-4 h after surgical excision. ? TROUBLESHOOTING (iv) Transfer the tissue to an empty plate. (v) Add William's E+ medium to the plate until the tissue is fully submerged in the medium.
It is not necessary to supplement the medium with additional cytokines. ! CAUTION The tissue must be submerged in the medium quickly to prevent it from drying. (vi) Gently scrape the luminal surface of the tissue with a scalpel to release the cholangiocytes into the medium (Fig. 2b,c, image 3) . c CRITICAL STEP Examine the cell suspension under a microscope after scraping the tissue and before collecting the cells into a centrifuge tube to ensure the mechanical dissociation has been successful. The epithelial cells should be released from the tissue as small clumps and should display columnar morphology (Fig. 2b,c, image 9 ). (vii) Collect the medium and cells into a 50-ml centrifuge tube using a 10-ml pipette. (viii) Wash the tissue again by adding~10 ml of fresh medium directly to the luminal surface of the tissue in the plate with a 10-ml pipette.
(ix) Repeat the process of scraping and washing until the entire epithelial layer is collected. By the end of this stage, the luminal side of the biliary tissue will appear smooth, losing the characteristic velvet-like appearance of the biliary epithelium (Fig. 2b ,c, images 1A(iii) and 1B(iii)). c CRITICAL STEP Scrape cautiously to avoid releasing fibrous tissue and debris into the cell suspension. ? TROUBLESHOOTING (x) Centrifuge the cells at 444g for 4 min at room temperature.
? TROUBLESHOOTING (xi) Aspirate the supernatant. (xii) Resuspend the pellet in 10 ml of William's E+ medium (regardless of pellet size) to wash the cells. If there is bile or debris remaining in the suspension, repeat this wash step. c CRITICAL STEP Remove large pieces of debris and fibrous tissue using a p1000 pipette, as these may not be easily removed by washing. ? TROUBLESHOOTING (xiii) Centrifuge the cells at 444g for 4 min at room temperature. (xiv) If you wish to lyse red cells to avoid erythrocyte contamination, resuspend the cells in 10 ml of ice-cold red cell lysis buffer and incubate the cell suspension on ice for up to 10 min. c CRITICAL STEP If red blood cells can be seen in the pellet after washing, red cell lysis is recommended in order to obtain as pure a population of cholangiocytes as possible upon initial plating, to encourage rapid formation and proliferation of COs. However, this step can be omitted, if the yield of primary cholangiocytes is very low, to avoid cell loss during the incubation and washing steps. ) before transferring to a well of a six-well plate for further dissection.
(ii) Using a scalpel, carefully dissect the tissue into pieces as small as possible, approximately <1 mm 3 (Fig. 4b, image 1A , and Fig. 4c, image 1B) . c CRITICAL STEP Care should be taken to ensure that the tissue is cut as small as possible so it can fit into a p1000 pipette tip (Fig. 4b,c, image 2) . Tissue dissection should be done as quickly as possible to prevent the tissue from drying out.
(iii) Add 1 ml of William's E+ medium with 50 ng/ml EGF and 10 μM (1 μl/ml) Y27632 to the dissected liver tissue. (iv) Transfer the dissected tissue and media to a 15-ml centrifuge tube, using a p1000 pipette (Fig. 4b,c, image 3) , and centrifuge at 300g for 2 min at room temperature (Fig. 4b,c (Fig. 4b,c, image 6(i) ). c CRITICAL STEP Typical morphology for COs plated from diced liver tissue <1 week after plating and >20 weeks after plating is displayed in Fig. 4d, left and Fig. 2b , image 3). c CRITICAL STEP DNase I must be added during the dissociation to prevent the cells from forming clumps. (iv) Place the plate on a heated orbital shaker at 170 r.p.m. and 37°C for 30 min. Ensure that the plate is secured to the orbital shaker. (v) Every 10 min, remove the tube from the rocker and gently pipette up and down with a p1000 pipette. c CRITICAL STEP Examine the cells under a microscope at these 10-min intervals to check the progress of the dissociation. The dissociation will be finished once all the tissue has been dissociated to a single-cell suspension, with only the collagen scaffold of the tissue remaining ( Supplementary Fig. 2b, image 4) . ? TROUBLESHOOTING (vi) After 30 min, or when a single-cell suspension has been obtained, stop the reaction by adding an equivalent volume of cold 1% (wt/vol) BSA in PBS. (vii) Filter the mixture through a 40-μm filter into a 15-ml centrifuge tube. c CRITICAL STEP Filter gently and do not force any material through the filter, as this will reduce viability and result in fibrous material in the final cell suspension. ? TROUBLESHOOTING (viii) Centrifuge at 444g for 4 min at room temperature.
(ix) Aspirate the supernatant, using a p1000 pipette. (x) Resuspend the pellet in 10 ml of red cell lysis buffer with 4 mg/ml DNase I and 10 μM Y27632. c CRITICAL STEP From this stage onward, aspiration of the supernatant should not be done using a vacuum pump aspirator, as this presents a risk of losing the pellet. (xi) Incubate the cells on ice in red cell lysis buffer for up to 10 min. (xii) Add an equivalent volume of 1% (wt/vol) BSA in PBS to the red cell lysis buffer and centrifuge at 444g for 4 min at room temperature. (xiii) Aspirate the supernatant, using a p1000 pipette, and resuspend in 1 ml of cold 1% (wt/vol) BSA in PBS with 4 mg/ml DNase I and 10 μM Y27632. (xiv) Repeat this wash step one more time to ensure the complete removal of the red cell lysis buffer, and resuspend the pellet once more in 1 ml of cold 1% (wt/vol) BSA in PBS with 4 mg/ml DNase I and 10 μM Y27632. for the number of wells being plated. For example, if plating nine wells, resuspend in 150 μl of William's E+ medium with 1.5 µg/ml R-spondin, 150 ng/ml EGF, 30 μM (3 μl/ml) Y27632 and 300 ng/ml DKK-1. c CRITICAL STEP Y27632 should always be freshly added at this stage and kept in the culture medium for 48 h to ensure maximal survival of the cholangiocyte cells. 4 Mix the Matrigel stock thoroughly with a p1000 pipette. c CRITICAL STEP Matrigel should be kept on ice throughout the entire procedure and must be mixed with care to avoid bubbles. 5 Add Matrigel to the cell suspension in a 2:1 ratio (66.7% (vol/vol)) and mix well. See 'Matrigel (66.7% (vol/vol)) solution' in the 'Reagent setup' section for instructions on how to calculate the amount of Matrigel required.
6 Use a p1000 pipette to plate the organoids in 50-µl Matrigel-medium domes, each in a well of a 24-well plate. To plate the dome, hold the tip of the p1000 pipette very close to the surface of the well, in the center, and slowly start pipetting. Move the pipette upward as the droplet forms. c CRITICAL STEP Do not go down to the second stop of the pipette, as this will form bubbles in the Matrigel dome. c CRITICAL STEP Mix thoroughly before plating each dome. ? TROUBLESHOOTING 7 Allow the Matrigel to solidify for 1-2 min in the plate heater. Gently tilt the plate to test that the Matrigel has solidified. 8 Invert the plate and keep it in the 37°C incubator for 30 min. This step should be omitted when plating dissected liver tissue (Step 2C) or EpCAM + single cells (Step 2D). c CRITICAL STEP Without the plate inversion step, cell clumps are likely to migrate to the bottom of the well and attach to the plate. If this happens, the cells will not be able to form organoids. ? TROUBLESHOOTING 9 Make up the 3× William's E+ medium solution to a final concentration of 500 ng/ml R-spondin, 50 ng/ml EGF, 10 μM (1 μl/ml) Y27632 and 100 ng/ml DKK-1 (±50 ng/ml HGF) by following the formula below:
Final volume of medium ¼Initial volume of medium prepared in Step 5 þ Initial volume of medium prepared in Step 5 2 ½ For example, if 1 ml of medium was initially prepared with 1.5 μg/ml R-spondin, 150 ng/ml EGF, 30 μM (3 μl/ml) Y27632 and 300 ng/ml DKK-1 (±50 ng/ml HGF and 6 μM FSK), add a further 2 ml of William's E+ medium without cytokines, for a total of 3 ml of medium with 500 ng/ ml R-spondin, 50 ng/ml EGF, 10 μM (1 μl/ml) Y27632 and 100 ng/ml DKK-1 (±50 ng/ml HGF and 2 μM FSK). 10 Add 1 ml of this supplemented medium per organoid well, using a 5-or 10-ml pipette. Place the cell cultures in the cell culture incubator. c CRITICAL STEP Add the medium slowly to the side of each well to avoid disrupting the Matrigel domes. c CRITICAL STEP When plating from primary cells, organoids from the CBD and gallbladder should begin to form within 2 d of plating and should be ready for the first passage within 5-7 d of initial plating (Fig. 2d, bottom, and Fig. 3c, bottom) . Organoids from liver biopsies or excised liver tissue should take~5-10 d to develop (Fig. 4d, right) and should be passaged when the plate is approaching 80% confluency. c CRITICAL STEP CO lines should always express the biliary markers CK19, CK7, Sox9 and GGT (Fig. 6a,b) and display ALP and GGT activity (Fig. 6c,d, respectively) . Established CO lines should be composed of a <99% pure population of CK19 + /CK7 + cells (Fig. 6e) . After approximately passage 2, CO lines derived from different tissues of origin or through different derivation methods will appear morphologically identical ( Supplementary Fig. 4a ).
? TROUBLESHOOTING
Cell culture: changing medium for maintenance of CO lines • Timing Variable, depending on cell line; hands-on time is 20 min every 48 h c CRITICAL Once primary cholangiocytes have been isolated and plated as described above, culture conditions for all CO lines are the same, and the following procedural steps for CO maintenance (Steps 15-30) apply equally to all CO lines, regardless of tissue of origin or derivation method. Equally, the characterization data shown in Fig. 6 are representative of CO lines derived from all tissue types or derivation methods. c CRITICAL Change the medium approximately every 48 h. 11 Prepare 1 ml of William's E+ medium per well, supplemented with 500 ng/ml R-spondin, 50 ng/ml EGF and 100 ng/ml DKK-1, for each well of a 24-well plate. In addition, 50 ng/ml HGF and 2 μM FSK can be added optionally for slow-growing lines requiring >5-7 d between passages. ? TROUBLESHOOTING 12 Carefully aspirate the old medium from the well. c CRITICAL STEP Tilt the plate when aspirating and aspirate from the edge of the well to avoid disrupting the Matrigel dome.
13 Add the new medium to all the wells, using a 5-or 10-ml pipette. 14 Continue to culture cells. c CRITICAL STEP When adding medium, tilt the plate and hold the pipette against the side of the well to avoid disrupting the Matrigel dome. Add the medium slowly.
Passaging of CO lines for maintenance • Timing 95 min
15 CO lines should be passaged approximately once every 5 d. However, the optimal time for passaging should be decided on basis of the confluency of the organoids; therefore, the cells should be examined daily (Fig. 5b, image 1) . c CRITICAL STEP Allowing the wells to become too confluent may lead to the collapse of organoids and subsequent cell death ( Supplementary Fig. 4b, image 2) . 16 Remove the medium and add 500 μl of cell recovery solution to each well. The pipette should be aimed at the center of the Matrigel dome and the cell recovery solution should be ejected forcefully to disrupt the surface of the dome. 17 Mechanically dissociate the remaining Matrigel dome by scraping with a p1000 pipette (Fig. 5a , image 1). c CRITICAL STEP Ensure that the whole surface of the well has been scraped to remove as many cells as possible. 18 Transfer the cells from each well to a 15-ml centrifuge tube. 19 Wash each well with 500 μl of cell recovery solution. (Optional) The same 500 μl can be carried across to each of the wells at this step to minimize the volume of cell recovery solution required for the washes. 20 Incubate the cells on ice at 4°C for 30 min to fully dissolve the Matrigel. 21 Centrifuge at 444g for 4 min at room temperature.
? TROUBLESHOOTING 22 Aspirate the supernatant. 23 If appropriate, use this wash step to split the cell pellet into multiple fractions. c CRITICAL STEP We recommend splitting the pellet appropriately to allow the generation of a single plate of organoids from a single pellet fraction. This is important in order to avoid prolonged use of the Matrigel master mix in the following steps. This can lead to Matrigel solidification and gravitation of larger cell clumps to the bottom of the mix, compromising uniform distribution of cells and seeding density. c CRITICAL STEP CO pellets can typically be split at a ratio between 1:4 and 1:6, depending on the number of wells in the initial plate and their confluency (Fig. 5a ). For reference, Fig. 5b , image 4 depicts a representative pellet for plating nine CO wells (~4.0 ×10 5 cells), obtained after a 1:4 split. 24 Resuspend in William's E+ medium, mixing well and using the following formula to calculate the minimum volume of medium required:
Volume of medium to add ml ð Þ¼ Number of pellets to be made after splitting
For example, for a 1:4 split, resuspend in 4 ml of medium. 25 Divide the cell suspension among multiple 15-ml centrifuge tubes, adding 1 ml per tube (e.g., for a 1:4 split, share the 4-ml volume equally among four 15-ml centrifuge tubes). 26 Centrifuge at 444g for 4 min at room temperature. 27 (Optional) Cryopreserve CO pellets at this point, if necessary, by resuspending each in 1 ml of CellBanker 2, transferring to a 2-ml cryovial and freezing immediately at −80°C. c CRITICAL STEP For long-term cryopreservation, COs should be stored in a liquid nitrogen cryobank. c CRITICAL STEP Cryovials should be transferred immediately to dry ice after removal from liquid nitrogen storage, to prevent uncontrolled thawing. CO cryovials should be thawed in a 37°C water bath, and the cells should be transferred immediately to prewarmed William's E+ medium supplemented with 10 µM Y27632 and centrifuged at 444g for 4 min at room temperature. Thawed cells can then be plated as described in Steps 3-10. j PAUSE POINT Cryopreserved COs can be stored for short-term storage (<6 weeks) at −80°C, but long-term storage at this temperature will affect the viability and overall health of the line. COs can be stored in a liquid nitrogen cryobank for an extended duration (>10 years), provided the temperature is not permitted to rise above −130°C.
28 Resuspend the pellet in a volume of 3× supplemented William's E+ medium (supplemented with 1.5 μg/ml R-spondin, 150 ng/ml EGF, 30 μM (3 μl/ml) Y27632 and 300 ng/ml DKK-1) as described in Step 5. See the '3× supplemented William's E+ solution' in the 'Reagent setup' section for instructions on how to prepare this solution and how to determine the appropriate volume to add. c CRITICAL STEP The number of plated wells of COs depends on the size of the resulting cell pellet. For example, a pellet of~4.0 × 10 5 cells (Fig. 5b, image 4) should be plated in nine wells. 29 Use a p200 pipette to mechanically dissociate the pellet to break up the organoids. This should typically be done~30-50 times, although the exact number will vary according to the starting size of the organoids. c CRITICAL STEP Organoids must be dissociated into small clumps of~10-20 cells to allow cysts to reform after splitting (Fig. 5b, image 5) . Mechanical dissociation should be done slowly to avoid damaging the cells. c CRITICAL STEP Organoid breaking must be carried out with a p200 pipette, even if the volume of 3× William's E+ medium required exceeds 200 μl. In that case, add the initial 200 μl and break the organoids as described in this step before adding the remaining volume of the medium. ? TROUBLESHOOTING 30 Plate the organoids onto a preheated 24-well tissue culture plate as described in Steps 3-10. c CRITICAL STEP Organoids should reform from small clumps into organoids 24-48 h after plating (Fig. 5b, image 7 (ii); enlarged image in Supplementary Fig. 2 , image 2). Organoids should proliferate rapidly and should reach~80% confluence 5 d after plating. ? TROUBLESHOOTING Preparation of 5 mg/ml collagen gel before generation of densified collagen scaffolds • Timing 10 min c CRITICAL Densified collagen scaffolds can be prepared to yield a sheet or tubular form. The sheet form produces a structure that has a well-defined thickness and density, and yields highly reproducible scaffolds, owing to the controlled nature of the process, whereas the collagen tube method is more technically challenging. c CRITICAL To produce a collagen gel, first mix a collagen gel precursor solution. This neutralizes the pH of the stock collagen solution and raises the ionic content, which induces the collagen fibrils to form a gel. Here, we produce two collagen sheets by preparing 2.5 ml of collagen precursor solution, which is prepared to a final collagen concentration of 5 mg/ml. 1 ml of this volume is sufficient to produce a collagen scaffold of a reproducible thickness (~750 μm), using the recommended specimen tubes. The quantities in parentheses represent the volumes required for a final volume of 2.5 ml, which is enough for two collagen sheets. c CRITICAL All equipment and reagents must be sterilized before use, and the following steps must take place in a class II biological safety cabinet under aseptic conditions. 31 Transfer 10× Medium 199 at a 10% (vol/vol) final volume to a sterile 50-ml tube (0.25 ml). 32 Calculate the volume of stock collagen solution required to yield a final collagen concentration of 5 mg/ml (1.25 ml). This is calculated by the following formula:
Precursor solution final volume ml ð Þ 33 Add sterile 1 M NaOH solution to the precursor solution at 2.5% (vol/vol) the volume of stock collagen solution to be added (31 μl). 34 Add sterile 7.5% (wt/vol) sodium bicarbonate solution to the precursor solution at 3% (vol/vol) the final volume (75 μl). c CRITICAL STEP This volume makes up a constituent volume of the collagen gel precursor solution and so must be accurate, or the concentration of collagen after gelation will vary. 35 Using a 1-ml syringe, transfer stock collagen solution, at the precalculated volume, to the precursor solution (1.25 ml). c CRITICAL STEP The stock collagen solution will be viscous because of its high concentration; use a syringe rather than a pipette to transfer the collagen accurately. ? TROUBLESHOOTING 36 Shake the collagen precursor solution vigorously until it develops a uniform color.
? TROUBLESHOOTING 37 Calculate the remaining volume of cell medium to be added to the precursor solution to reach the required final volume (0.894 ml) and transfer it to the Falcon tube containing the precursor solution. 38 Centrifuge the collagen precursor solution at 200g for 1 min at 4°C to remove air bubbles and then return the liquid to the bottom of the Falcon tube.
Generation of densified collagen scaffolds
39 Generate collagen scaffolds either as flat sheets (option A) or as tubes ( Fig. 1c; option B) . If using commercially produced PGA scaffolds, proceed to the next step. (A) Fabrication of densified collagen sheets • Timing 1-2 h c CRITICAL Larger-sized densified collagen sheets are possible with larger (flat-bottom) containers (e.g., a 24-well plate). To produce collagen sheets of the same thickness, the collagen precursor solution should be poured into the container such that the height of the solution is 25 mm. (i) Using a 1-ml syringe and 18-gauge needle, transfer the 5 mg/ml collagen precursor solution to a specimen tube until the height of the solution is 25 mm (Fig. 7b, image 1) . Repeat as necessary. c CRITICAL STEP Avoid inserting air bubbles into the mixture. Add collagen solution slowly. (ii) Gel the collagen solution by placing the specimen tube in a 37°C incubator for 30 min. c CRITICAL STEP To maintain sterility, transfer the specimen tube within an upside down 15-ml Falcon tube. ? TROUBLESHOOTING (iii) Tightly roll three sheets of absorbent paper towels into a cylinder roughly 5 mm in diameter and secure it with autoclave tape. (iv) Using scissors, cut the paper cylinder to 25 mm in length. Flatten the end by pushing the cylinder against a sterile surface (i.e., a 10-cm plate). Autoclave both the paper cylinder and a nylon membrane. c CRITICAL STEP The paper cylinder must have a flat edge in order to contact suitably and thus dry the collagen gel evenly. (v) Using scissors, cut a piece of nylon membrane into a round piece of a slightly smaller diameter than that of the specimen tube. (vi) Return the specimen tube to the class II biological safety cabinet. Carefully place the nylon membrane on top of the gel and then place the paper towel wadding into the specimen tube, on top of the membrane (Fig. 7b, image 2(i) ). (vii) Apply very light finger pressure to the top of the wadding so as to make good contact with the gel and then leave the gel to densify for~1 h (Fig. 7b, images 1-3(i) ). ? TROUBLESHOOTING (viii) Monitor the densification process every 5-10 min to ensure that the wadding is in contact with the gel, and occasionally apply light pressure to keep the wadding in place. c CRITICAL STEP Applying too much pressure will rip the top surface of the gel. ? TROUBLESHOOTING (ix) The densification is terminated when the paper towel has almost reached the bottom of the specimen tube and no water can be further removed (Fig. 7b, image 3(ii) ). Once this has occurred, remove the paper wadding; the collagen gel and nylon membrane should be adhered to the wadding. ? TROUBLESHOOTING (x) Using tweezers, carefully grip the edge of the collagen sheet and peel it away from the paper wadding. (xi) The nylon membrane is likely to remain attached to the collagen sheet. By gripping the nylon sheet with tweezers, peel this away from the collagen sheet (Fig. 7b, image 4) . c CRITICAL STEP Avoid ripping the collagen sheet by gently peeling it away from the nylon membrane. ? TROUBLESHOOTING (xii) Wash the scaffold in William's E+ medium in a six-well plate to remove the pink coloration. (xiii) For storage, place the densified collagen sheet in fresh William's E+ medium or PBS in a six-well plate or another appropriate container (Fig. 7b, image 5) . Seal the plate with Parafilm and store it at 4°C. Otherwise, proceed to the next step. j PAUSE POINT The densified collagen sheet can be stored at 4°C for up to 3 months before seeding. (xiv) Warm the collagen sheet to 37°C before cell seeding, by placing it in an incubator. Cells can be seeded onto the surface of the collagen sheet at this point and cultured for several months as described in the subsequent steps. (B) Fabrication of densified collagen tubes • Timing~5-26 h (i) Using a 1-ml pipette, transfer the precursor solution to the densification chamber until the chamber is full (~1.5 ml; Fig. 8c, image 1) . c CRITICAL STEP Avoid inserting air bubbles into the mixture. Add collagen solution slowly. (ii) Gel the collagen solution by placing the densification chamber in a 37°C incubator for 30-60 min.
? TROUBLESHOOTING (iii) To form a collagen tube, it is necessary to dislodge the collagen gel from the top of the funnel to encourage the gel surface to drop. To do this, use a sterile pair of tweezers under a sterile class II biological safety cabinet to gently peel the collagen gel away from the walls of the chamber (Fig. 8c, image 2 ). (iv) Loosen the screws attaching the base to the funnel. (v) Return the densification chamber to the incubator. Monitor the chamber regularly for 30 min until the level of the collagen gel drops to the top of the metallic wire (Fig. 8c, image 3) . c CRITICAL STEP The top end of the metallic wire, embedded in the collagen, will prevent the gel surface from dropping further. Water will continue to be removed through evaporation around the sides of the funnel to yield a tubular structure. c CRITICAL STEP There should be a visible gap between the collagen gel and the edges of the funnel. ? TROUBLESHOOTING (vi) Monitor the densification chamber in the incubator for a further 4-24 h to allow for evaporation of the water phase of the gel (Fig. 8b, panel 4) . c CRITICAL STEP It is important to monitor the collagen gel and prevent the tube from overdrying, on the basis of the humidity conditions of the incubator. (vii) Continue the process until the vast majority of water has evaporated. The collagen scaffold should consist of a dense and thin cylindrical component around a wire core, with a larger region near the top of the funnel (Fig. 8c, image 4) . ? TROUBLESHOOTING (viii) Transfer 4 ml of William's E+ medium to a six-well plate. Use a sterile pair of tweezers to grip the top of the collagen tube and slowly pull it upward over the end of the metallic wire (Fig. 8c,  image 5 ). c CRITICAL STEP Be careful not to damage the collagen tube with the tweezers or the end of the metallic wire. ? TROUBLESHOOTING (ix) Place the collagen tube in a six-well plate containing William's E+ medium for storage. The pink coloration will disappear from the collagen tube over several hours (Fig. 8d , images 1 and 2). (x) Before surgical implantation, it is necessary to trim away the excess collagen sheet and cut a suitable length of tube for the experiment. Place the tube under a dissecting microscope and use a surgical scalpel to cleanly trim any excess collagen (Fig. 8d, image 3 ). (xi) Determine a suitable length of collagen tube along the scaffold. Pick a region that is cylindrical in nature (likely the middle section). Use a surgical scalpel to cleanly cut across the tube to yield the required length for the particular application (Fig. 8d, image 4) . c CRITICAL STEP Trimming the tube is a particularly difficult step, probably requiring the assistance of an experienced surgeon. Be extremely careful not to cut into the lumen of the tube. Doing so will result in leakages when the tube is perfused. (xii) Observe the patent lumen under phase contrast with an inverted microscope (Fig. 8d (Fig. 1d) . c CRITICAL The use of an optimal CO line is essential for scaffold seeding. Suboptimal lines will result in reduced cell attachment, proliferation and long-term viability. All CO lines should express the biliary markers CK19, CK7, Sox9 and GGT (Fig. 6a,b) and display ALP and GGT activity (Fig. 6c,d ). Healthy CO lines should require passaging every 5 d (Fig. 5b, image 1) . CO lines that fail to meet these criteria should not be considered for scaffold seeding. See the 'Troubleshooting' section for Steps 10, 11, 29 and 30 for guidance on how to improve the quality of a suboptimal CO line. (A) Seeding on densified collagen sheets • Timing~2 h 35 min-4 h c CRITICAL Collagen scaffolds must be of an optimal quality to be used for seeding. Batch-test the stock collagen solution used for collagen densification for cell attachment and proliferation and confirm that the densification process has completed fully (see 'Troubleshooting' section for
Step 39A) and the scaffold has not dried out during storage to ensure the quality of the collagen scaffolds. c CRITICAL For long-term storage, maintain the collagen scaffolds in PBS to prevent them from drying out. (i) Remove the PBS and place the collagen scaffold in a dry 24-well tissue culture plate; then place it in an incubator for 30 min-1 h, or until the PBS has evaporated and residues on the surface are no longer visible. c CRITICAL STEP Drying the scaffold before seeding is necessary, as the presence of excess liquid on the scaffold's surface may prevent cell attachment. This step is required both if the scaffold has been stored long term and if seeding takes place immediately after fabrication of the densified collagen scaffold. c CRITICAL STEP Allowing the scaffold to dry for a prolonged period following evaporation of the medium/PBS may affect the collagen fiber micro-architecture.
(ii) Remove the organoids from the Matrigel domes using cell recovery solution and incubate them on ice for 30 min as described in Steps 16-26. An optimal seeding density of 1.5 × 10 6 cells/cm 2 has been observed to give confluent scaffolds over a short period of time; the number of wells required for the required surface area should be calculated using the following formula: ? TROUBLESHOOTING (v) Seed the cells by directly pipetting this solution onto the scaffold's surface with a p10 pipette (Fig. 9b, images 3(i) and 3(ii) ). c CRITICAL STEP To achieve a homogeneous attachment, it is recommended to seed multiple 5-µl aliquots in different positions all over the scaffold surface. ? TROUBLESHOOTING (vi) After seeding on collagen scaffolds, keep the plate in a 37°C incubator for 1-2 h to allow the cells to attach to the scaffold. c CRITICAL STEP Monitor the scaffolds every 30 min to avoid drying the cells out. ? TROUBLESHOOTING (vii) Prepare 2 ml of William's E+ medium supplemented with 500 ng/ml R-spondin, 50 ng/ml EGF, 100 ng/ml DKK-1 and 10 μM Y27632 for each scaffold.
(viii) To add the medium, tilt the plate and slowly add the medium from the bottom of the well (Fig. 9b, image 5 ). c CRITICAL STEP Medium must be added as slowly as possible, using a p1000 pipette. Care must be taken to avoid disrupting the scaffold when adding the medium. ? TROUBLESHOOTING (ix) Culture the seeded scaffold for 4 d before the first medium change, in order to maximize cell attachment. After this period, replace the medium with 500 µl of William's E+ medium supplemented with 500 ng/ml R-spondin, 50 ng/ml EGF and 100 ng/ml DKK-1 every other day. c CRITICAL STEP When the medium is changed, all previous medium must first be aspirated. Care must be taken to avoid disrupting the scaffold during medium aspiration. c CRITICAL STEP COs will start growing and expanding on the scaffold after a first lag phase (lasting~4-5 d after seeding); then confluency should be reached in~2 weeks, according to the age of the cell line (Fig. 9d,e) . ? TROUBLESHOOTING (B) Seeding onto the lumen of densified collagen tubes • Timing 2 h 30 min-3 h 30 min (i) Working under aseptic conditions, transfer the densified collagen tube onto a dry 10-cm plate.
(ii) Leave it to dry under a class II biological safety cabinet for approximately half an hour, or until almost all the residual PBS has evaporated. c CRITICAL STEP Prepare the CO cell suspension as detailed in Step 40B(iii,iv)) during the waiting time described in Step 40B(ii). For best results, this should be done under a dissecting microscope (Fig. 10b, image 2) . c CRITICAL STEP Cannulation of the tube should ideally be performed by an experienced surgeon. Improper attempts at cannulation can result in disruption of the construct wall beyond repair. (vii) Use a p200 pipette to transfer the cell suspension to a 25-or 50-μl Hamilton syringe. c CRITICAL STEP It is highly advisable to use Hamilton syringes, as recommended in the 'Equipment' list, or some other model of small-volume syringes with removable needles and no dead space. This is due to the very low volume of cell suspension required for seeding, which is smaller than the dead space in standard needles. (viii) Slowly depress the plunger on the syringe to deposit the cell suspension in the lumen of the tube while simultaneously removing the needle from the tube in order to distribute the cells evenly along the tube lumen (Fig. 10b, image 3) . ? TROUBLESHOOTING 
Troubleshooting
Troubleshooting advice can be found in Table 1 . Complete the dissection step as quickly as possible PCV due to stress of mechanical dissociation Ensure that the dissected liver pieces are as small as possible so they can fit into the tip of a p1000 pipette without difficulty PCV due to prolonged cold storage Process the tissue as soon as possible after surgical excision PCV due to lack of necessary cytokines in the medium Ensure that the medium contains 150 ng/ml EGF and 10 μM Y27632 at every stage PCV due to poor quality of tissue culture medium and reagents (Matrigel or cytokines) The absorbent paper wadding has poor contact with the collagen gel and so cannot remove water effectively
Remove the paper wadding from the specimen tube and flatten the end in contact with the collagen gel. Once sufficiently flat, return it to densification chamber Step Problem
Possible reason Solution
As the paper wadding absorbs water, it expands and becomes wedged in the specimen tube, preventing further densification Gently remove the paper wadding from the specimen tube and replace it with a fresh roll with a slightly reduced diameter 39A(ix) Following densification steps and removal of paper wadding, the specimen tube is empty Collagen solution has been prematurely absorbed into the paper wadding before gelation
Repeat the process and extend the time for collagen gelation from 30 min to 1 h Test gelation by carefully pressing the metal spatula against the top surface. Only add paper wadding once you are sure that the collagen has gelled 39A(xi)
Collagen sheet was not attached to paper wadding on its final removal After the removal of the wadding, the collagen sheet remains at the bottom of the specimen tube
The scaffold can be removed carefully with a pair of tweezers or by some PBS flushed into the specimen tube
Once removed from the densification chamber, the lower part of the scaffold retains a gel-like structure Densification has been stopped prematurely, causing the lower part of the collagen sheet to retain a higher water content
Return the scaffold to the densification chamber and continue the densification process with fresh paper wadding 39B(ii) Before collagen gelation, the level of the collagen solution has dropped
The collagen precursor solution is leaking out of the bottom of the funnel of the densification chamber
Keep the chamber upright and carefully tighten the screws such that the base is firmly attached to the funnel. Add an extra volume of collagen precursor solution until the funnel is once again full The level of the collagen gel has dropped below the top of the metallic wire
The volume of collagen above the wire was unable to stop the collagen gel from dropping below the wire Use scissors to remove a couple of millimeters of length from the top of the metallic wire. Repeat the collagen gelling process
The level of the collagen gel has not dropped to the top of the metallic wire
The paper towels at the base are not in sufficient contact with the gel and so water is not being drawn out
Repeat the process. When loosening the screws, do not displace the base away from the funnel, thereby keeping the paper towels in contact with the bottom of the collagen gel Excessive breaking of the CO clumps, reducing cell viability Use a p200 pipette instead of a p20 to break the CO clumps Pipette more slowly when breaking the CO clumps Increase the amount of medium to 1 ml and change it very carefully every 4 d Y27632 was not added to the medium Ensure that fresh Y27632 is added to the medium when seeding Suboptimal CO line All CO lines should express the biliary markers CK19, CK7, Sox9 and GGT (Fig. 6a,b) and display ALP and GGT activity (Fig. 6c,d ). Healthy CO lines should be proliferating at a rate requiring passaging every 5 d (Fig. 5b, (Figs. 2e, 3d and 4e) . Furthermore, 95% of plated samples derived from excised bile ducts (when appropriately flushed of bile after excision) and 100% of samples derived from gallbladders, liver biopsies and ERCP brushings yield robust CO lines within 5 d of initial plating (Supplementary Table 1 ). CO lines can be derived from EpCAM + liver samples with an approximate efficiency of 66% (Supplementary Table 1 ). Although it is important to derive lines from fresh, highly viable primary tissue to ensure the most reliable results, robust, highly proliferative CO lines can also be derived from poor-quality samples with low cell numbers (Supplementary Fig. 5 ). CO lines can subsequently be passaged approximately every 5 d and can typically be split in a 1:4-1:6 ratio for further expansion, analysis or cryopreservation.
The resulting organoids consist of a near-homogeneous (>99%) population of cholangiocytes (Fig. 6e) . They express biliary markers such as CK19, CK7, Sox9 and GGT (Fig. 6a) at levels comparable to those of primary tissue (Fig. 6b) in the absence of hepatic markers such as albumin (Fig. 6a) . Furthermore, CO lines exhibit key cholangiocyte functions, such as ALP and GGT activity (Fig. 6c,d ). COs also display functional secretory capacity, as measured by the luminal secretion of rhodamine 123 (see Fig. 2a -c in ref. 4 ) and bile acid transport, as measured by export of the fluorescently labeled bile acid CLF (see Fig. 2d -f in ref. 4 ). In addition, COs respond appropriately to hormonal signals such as secretin and somatostatin (see Fig. 2i ,j in ref. 4 ). For further validation, COs can be transplanted under the kidney capsule of immunocompromised mice, where they form tubular structures retaining expression of biliary markers such as CK7 and CK19 and are capable of longterm survival (see Supplementary Fig. 7 in ref. 4 ). COs can be seeded onto both densified collagen and PGA scaffolds to form bioengineered biliary tissue. In addition, COs can be seeded onto the lumen of tubular densified collagen scaffolds (Fig.  11e) . The efficiency of cell attachment following seeding is variable among CO lines. However, following attachment, the cells demonstrate a unique potential to expand and fully populate the scaffold. Therefore, it is always possible to generate confluent constructs by varying how long the scaffolds are maintained in culture. The resulting tissue expresses key cholangiocyte markers such as CK19 and CK7 (Fig. 11a,c,e) and exhibits biliary function such as GGT activity (Fig. 11b,d,f) . These constructs can be used to successfully reconstruct or repair the biliary tree of immunocompromised mice (see Figs. 4 and 6 in ref. 4 ) while retaining the expression of biliary markers and function following transplantation (see Figs. 4 and 6 in ref. 4 ).
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Sample size
No sample size calculations were performed. Sample sizes were chosen based on previous experience with the assays in the lab.
Data exclusions No data were excluded from the analyses Replication All experimental findings described in this article are consistent with the findings described in Sampaziotis et al; Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids; Nat Med. Randomization Randomization was not applicable to this study as all comparisons were performed between different populations of cells (organoids vs mouse embryonic feeder controls), rather than a baseline population that was treated or manipulated in different ways. However, within each population, samples for analysis were chosen randomly and all analyses are representative.
Blinding
Blinding was not required for the analyses performed in this study as all experimental data were collected with the aim of characterizing and validating the systems described in the protocol. Where groups of cells were compared, blinding was not possible as the identity of the cells was apparent to an experienced researcher based on their morphology.
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